ATF4 knockout was found to protect against diet-induced obesity, hypertriglyceridemia, and hepatic steatosis by significantly decreasing the expression of lipogenic genes, such as PPARγ, SREBP-1c, and FASN [17]. Here, PPARG is linked to fatty liver disease.